Senti Biosciences (SNTI) Return on Equity (2021 - 2025)

Senti Biosciences has reported Return on Equity for 5 years, with the latest figure at 0.1% in Q4 2025.

• For the quarter ending Q4 2025, Return on Equity changed N/A year-over-year to 0.1%; the trailing twelve-month figure through Dec 2025 stood at 0.1% (changed N/A YoY), and the FY2025 full-year result was 0.04%, changed N/A from the prior year.
• Return on Equity for Q4 2025 stood at 0.1%, down from 0.03% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q2 2024, with the low at 0.1% in Q4 2025.
• Average Return on Equity over 5 years is 0.01%, with a median of 0.0% recorded in 2022.
• Year-over-year, Return on Equity gained 3 bps in 2023 and decreased 3 bps in 2025.
• Tracing SNTI's Return on Equity over 5 years: stood at 0.0% in 2021, then sank by 245 bps to 0.0% in 2022, then soared by 150 bps to 0.0% in 2023, then slumped by 101 bps to 0.0% in 2024, then slumped by 1062929 bps to 0.1% in 2025.
• The last three Return on Equity figures came in at 0.1% (Q4 2025), 0.03% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.

Peer Comparison